Baker Tilly Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $807K | Buy |
|
|||||
|
2025
Q2 | $866K | Sell |
|
|||||
|
2025
Q1 | $889K | Buy |
|
|||||
|
2024
Q4 | $724K | Sell |
|
|||||
|
2024
Q3 | $1.23M | Sell |
|
|||||
|
2024
Q2 | $1.88M | Sell |
|
|||||
|
2024
Q1 | $5.12M | Sell |
|
|||||
|
2023
Q4 | $4.28M | Sell |
|
|||||
|
2023
Q3 | $4.04M | Sell |
|
|||||
|
2023
Q2 | $4.67M | Buy |
|
|||||
|
2023
Q1 | $4.49M | Sell |
|
|||||
|
2022
Q4 | $4.73M | Buy |
|
|||||
|
2022
Q3 | $3.2M | Sell |
|
|||||
|
2022
Q2 | $3.62M | Sell |
|
|||||
|
2022
Q1 | $3.65M | Buy |
|
|||||
|
2021
Q4 | $3.47M | Buy |
|
|||||
|
2021
Q3 | $2.58M | Buy |
|
|||||
|
2021
Q2 | $2.24M | Buy |
|
|||||
|
2021
Q1 | $1.65M | Buy |
|
|||||
|
2020
Q4 | $1.26M | Buy |
|